aristolochic acid i has been researched along with alprostadil in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Kim, JM; Manchanda, R; Tsang, BK | 1 |
| Liu, CX; Ma, YY; Sun, D; Zhang, L | 1 |
3 other study(ies) available for aristolochic acid i and alprostadil
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Role of prostaglandins in the suppression of apoptosis in hen granulosa cells by transforming growth factor alpha.
Topics: Alprostadil; Animals; Apoptosis; Arachidonic Acid; Arachidonic Acids; Aristolochic Acids; Cells, Cultured; Chickens; Chromatin; Culture Media, Serum-Free; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; DNA Fragmentation; Enzyme Inhibitors; Female; Granulosa Cells; Ibuprofen; Nitrobenzenes; Phenanthrenes; Phospholipases A; Prostaglandins; Prostaglandins E; Prostaglandins F; Sulfonamides; Transforming Growth Factor alpha | 2001 |
Protective effect of prostaglandin E1 on renal microvascular injury in rats of acute aristolochic acid nephropathy.
Topics: Alprostadil; Animals; Aristolochia; Aristolochic Acids; Blotting, Western; Drug Evaluation, Preclinical; Female; Fibrinolytic Agents; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Kidney; Microvessels; Nephritis, Interstitial; Plant Extracts; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A | 2011 |